lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide

C137H170ClF6LiN28O32 — CID 165050290

IUPAClithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide
SMILESCC(C)(C)O.CCOC(=O)c1ccc(Nc2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)c(OC)c1.CC[C@@H]1C(=O)N(C)c2cnc(Cl)nc2N1C1CCCC1.CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NCCCCNC(=O)COc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)cc3OC)nc2N1C1CCCC1.CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)O)cc3OC)nc2N1C1CCCC1.COc1cc(C(C)=O)ccc1N.NCCCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.[Li+].[OH-]
InChIInChI=1S/C41H47N9O9.C24H31N5O4.C22H27N5O4.C19H22N4O6.C14H19ClN4O.C9H11NO2.C4H10O.2C2HF3O2.Li.H2O/c1-4-27-39(56)48(2)29-21-44-41(47-35(29)49(27)24-10-5-6-11-24)45-26-15-14-23(20-31(26)58-3)36(53)43-19-8-7-18-42-33(52)22-59-30-13-9-12-25-34(30)40(57)50(38(25)55)28-16-17-32(51)46-37(28)54;1-5-18-22(30)28(3)19-14-25-24(27-21(19)29(18)16-9-7-8-10-16)26-17-12-11-15(13-20(17)32-4)23(31)33-6-2;1-4-16-20(28)26(2)17-12-23-22(25-19(17)27(16)14-7-5-6-8-14)24-15-10-9-13(21(29)30)11-18(15)31-3;20-8-1-2-9-21-15(25)10-29-13-5-3-4-11-16(13)19(28)23(18(11)27)12-6-7-14(24)22-17(12)26;1-3-10-13(20)18(2)11-8-16-14(15)17-12(11)19(10)9-6-4-5-7-9;1-6(11)7-3-4-8(10)9(5-7)12-2;1-4(2,3)5;2*3-2(4,5)1(6)7;;/h9,12-15,20-21,24,27-28H,4-8,10-11,16-19,22H2,1-3H3,(H,42,52)(H,43,53)(H,44,45,47)(H,46,51,54);11-14,16,18H,5-10H2,1-4H3,(H,25,26,27);9-12,14,16H,4-8H2,1-3H3,(H,29,30)(H,23,24,25);3-5,12H,1-2,6-10,20H2,(H,21,25)(H,22,24,26);8-10H,3-7H2,1-2H3;3-5H,10H2,1-2H3;5H,1-3H3;2*(H,6,7);;1H2/q;;;;;;;;;+1;/p-1/t27-,28?;18-;16-;;10-;;;;;;/m111.1....../s1
InChIKeyQLWLVOXFPRHRPW-PDYVTPPCSA-M
MW2877.41 g/mol
LogP12.49
Rot. Bonds40

About lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide

lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide (PubChem CID 165050290) has the molecular formula C137H170ClF6LiN28O32 and a molecular weight of 2877.41 g/mol. Its IUPAC name is lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide.

Molecular Properties

Compound Namelithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide
PubChem CID165050290
Molecular FormulaC137H170ClF6LiN28O32
Molecular Weight2877.41 g/mol
Exact Mass2875.23
IUPAC Namelithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide
SMILESCC(C)(C)O.CCOC(=O)c1ccc(Nc2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)c(OC)c1.CC[C@@H]1C(=O)N(C)c2cnc(Cl)nc2N1C1CCCC1.CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NCCCCNC(=O)COc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)cc3OC)nc2N1C1CCCC1.CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)O)cc3OC)nc2N1C1CCCC1.COc1cc(C(C)=O)ccc1N.NCCCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.[Li+].[OH-]
InChIInChI=1S/C41H47N9O9.C24H31N5O4.C22H27N5O4.C19H22N4O6.C14H19ClN4O.C9H11NO2.C4H10O.2C2HF3O2.Li.H2O/c1-4-27-39(56)48(2)29-21-44-41(47-35(29)49(27)24-10-5-6-11-24)45-26-15-14-23(20-31(26)58-3)36(53)43-19-8-7-18-42-33(52)22-59-30-13-9-12-25-34(30)40(57)50(38(25)55)28-16-17-32(51)46-37(28)54;1-5-18-22(30)28(3)19-14-25-24(27-21(19)29(18)16-9-7-8-10-16)26-17-12-11-15(13-20(17)32-4)23(31)33-6-2;1-4-16-20(28)26(2)17-12-23-22(25-19(17)27(16)14-7-5-6-8-14)24-15-10-9-13(21(29)30)11-18(15)31-3;20-8-1-2-9-21-15(25)10-29-13-5-3-4-11-16(13)19(28)23(18(11)27)12-6-7-14(24)22-17(12)26;1-3-10-13(20)18(2)11-8-16-14(15)17-12(11)19(10)9-6-4-5-7-9;1-6(11)7-3-4-8(10)9(5-7)12-2;1-4(2,3)5;2*3-2(4,5)1(6)7;;/h9,12-15,20-21,24,27-28H,4-8,10-11,16-19,22H2,1-3H3,(H,42,52)(H,43,53)(H,44,45,47)(H,46,51,54);11-14,16,18H,5-10H2,1-4H3,(H,25,26,27);9-12,14,16H,4-8H2,1-3H3,(H,29,30)(H,23,24,25);3-5,12H,1-2,6-10,20H2,(H,21,25)(H,22,24,26);8-10H,3-7H2,1-2H3;3-5H,10H2,1-2H3;5H,1-3H3;2*(H,6,7);;1H2/q;;;;;;;;;+1;/p-1/t27-,28?;18-;16-;;10-;;;;;;/m111.1....../s1
InChIKeyQLWLVOXFPRHRPW-PDYVTPPCSA-M
XLogP12.49
TPSA800.73 Ų
H-Bond Donors14
H-Bond Acceptors46
Rotatable Bonds40
Heavy Atoms205
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002877.41
LogP ≤ 512.49
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1046

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide?
The IUPAC name of lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide (CID 165050290) is lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide.
What is the SMILES notation for lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide?
The canonical SMILES for lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide is CC(C)(C)O.CCOC(=O)c1ccc(Nc2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)c(OC)c1.CC[C@@H]1C(=O)N(C)c2cnc(Cl)nc2N1C1CCCC1.CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NCCCCNC(=O)COc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)cc3OC)nc2N1C1CCCC1.CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)O)cc3OC)nc2N1C1CCCC1.COc1cc(C(C)=O)ccc1N.NCCCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.[Li+].[OH-].
What is the InChIKey of lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide?
The InChIKey is QLWLVOXFPRHRPW-PDYVTPPCSA-M. The full InChI is InChI=1S/C41H47N9O9.C24H31N5O4.C22H27N5O4.C19H22N4O6.C14H19ClN4O.C9H11NO2.C4H10O.2C2HF3O2.Li.H2O/c1-4-27-39(56)48(2)29-21-44-41(47-35(29)49(27)24-10-5-6-11-24)45-26-15-14-23(20-31(26)58-3)36(53)43-19-8-7-18-42-33(52)22-59-30-13-9-12-25-34(30)40(57)50(38(25)55)28-16-17-32(51)46-37(28)54;1-5-18-22(30)28(3)19-14-25-24(27-21(19)29(18)16-9-7-8-10-16)26-17-12-11-15(13-20(17)32-4)23(31)33-6-2;1-4-16-20(28)26(2)17-12-23-22(25-19(17)27(16)14-7-5-6-8-14)24-15-10-9-13(21(29)30)11-18(15)31-3;20-8-1-2-9-21-15(25)10-29-13-5-3-4-11-16(13)19(28)23(18(11)27)12-6-7-14(24)22-17(12)26;1-3-10-13(20)18(2)11-8-16-14(15)17-12(11)19(10)9-6-4-5-7-9;1-6(11)7-3-4-8(10)9(5-7)12-2;1-4(2,3)5;2*3-2(4,5)1(6)7;;/h9,12-15,20-21,24,27-28H,4-8,10-11,16-19,22H2,1-3H3,(H,42,52)(H,43,53)(H,44,45,47)(H,46,51,54);11-14,16,18H,5-10H2,1-4H3,(H,25,26,27);9-12,14,16H,4-8H2,1-3H3,(H,29,30)(H,23,24,25);3-5,12H,1-2,6-10,20H2,(H,21,25)(H,22,24,26);8-10H,3-7H2,1-2H3;3-5H,10H2,1-2H3;5H,1-3H3;2*(H,6,7);;1H2/q;;;;;;;;;+1;/p-1/t27-,28?;18-;16-;;10-;;;;;;/m111.1....../s1.
What are the key properties of lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide?
lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide has a molecular weight of 2877.41 g/mol, XLogP of 12.49, 40 rotatable bonds, 14 hydrogen bond donors, and 46 hydrogen bond acceptors.
Where does this data come from?
All data for lithium;N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;1-(4-amino-3-methoxyphenyl)ethanone;(7R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7H-pteridin-6-one;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-N-[4-[[2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetyl]amino]butyl]-3-methoxybenzamide;4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid;ethyl 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoate;2-methylpropan-2-ol;bis(2,2,2-trifluoroacetic acid);hydroxide is sourced from PubChem (CID 165050290), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).